Each filer's latest filing for 92941V407 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
|
Bellevue Group AG
13G
|
10.6% |
10/7/2026
Event 9/10/2026
|
||
| Bellevue Group AG | 10.6% | |||
| Bellevue Asset Management AG | 10.6% | |||
|
Perceptive Advisors LLC
13G/A
|
10.0% |
11/16/2026
Event 9/30/2026
|
||
| Perceptive Advisors LLC | 10.0% | |||
| Joseph Edelman | 10.0% | |||
| Perceptive Life Sciences Master Fund, Ltd. | 10.0% | |||
|
venBio Global Strategic Fund V, L.P.
13G/A
|
10.0% |
11/16/2026
Event 9/30/2026
|
||
| venBio Global Strategic Fund V, L.P. | 10.0% | |||
| venBio Global Strategic GP V, LLC | 10.0% | |||
|
Logos Global Management LP
13G/A
|
10.0% |
11/17/2026
Event 9/30/2026
|
||
| Logos Global Management LP | 10.0% | |||
| Logos Global Management GP LLC | 10.0% | |||
| Logos Global Master Fund LP | 4.9% | |||
| Logos GP LLC | 4.9% | |||
| Logos Opportunities Fund V LP | 9.5% | |||
| Logos Opportunities V GP LLC | 9.5% | |||
| Arsani William | 10.0% | |||
| Graham Walmsley | 9.5% | |||
|
Orbimed Advisors LLC
13D
|
10.0% |
8/5/2026
Event 7/27/2026
|
||
| Orbimed Advisors LLC | 10.0% | |||
| OrbiMed Capital GP X LLC | 8.7% | |||
| OrbiMed Capital GP X, LP | 8.7% | |||
| OrbiMed Genesis GP LLC | 1.3% | |||
|
RTW Fund Group GP, LLC
13G/A
|
9.9% |
11/16/2026
Event 9/30/2026
|
||
| RTW Fund Group GP, LLC | 9.9% | |||
| Roderick Wong | 9.9% | |||
|
Ameriprise Financial, Inc.
13G
|
8.6% |
11/16/2026
Event 9/30/2026
|
||
| Ameriprise Financial, Inc. | 8.6% | |||
| Columbia Management Investment Advisers, LLC | 8.6% | |||
| Columbia Small Cap Growth Fund | 6.3% | |||
|
Invus Global Management, LLC
13G
|
7.2% |
9/17/2026
Event 9/11/2026
|
||
| Invus Public Equities, L.P. | 6.3% | |||
| Invus Public Equities Advisors, LLC | 6.3% | |||
| Invus Global Management, LLC | 6.3% | |||
| Siren, L.L.C. | 6.3% | |||
| Avicenna Life Sci Master Fund LP | 0.9% | |||
| Avicenna Life Sci Master GP LLC | 0.9% | |||
| Ulys, L.L.C. | 0.9% | |||
| Raymond Debbane | 7.2% | |||
|
Spruce Street Capital LP
13G
|
6.4% |
11/13/2026
Event 9/30/2026
|
||
| Spruce Street Capital LP | 6.4% | |||
| Alex R. Rosen | 6.4% | |||
| Simon Basseyn | 6.4% | |||
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (5) | ||||
| Janus Henderson Group Ltd. 13G/A | 3.0% |
11/16/2026
Event 9/30/2026
|
||
|
ADAR1 Capital Management, LLC
13G/A
|
2.5% |
11/16/2026
Event 9/30/2026
|
||
| ADAR1 Capital Management, LLC | 2.5% | |||
| Daniel Schneeberger | 2.5% | |||
|
AI Biotechnology LLC
13D/A
|
1.2% |
11/20/2026
Event 11/13/2026
|
||
| AI Biotechnology LLC | 1.2% | |||
| Access Industries Holdings LLC | 1.2% | |||
| Access Industries Management, LLC | 1.2% | |||
| Len Blavatnik | 1.2% | |||
| Zhang Xiaofan 13G/A | 0.6% |
8/13/2026
Event 8/13/2026
|
||
|
Nantahala Capital Management, LLC
13G/A
|
0.5% |
11/13/2026
Event 9/30/2026
|
||
| Nantahala Capital Management, LLC | 0.5% | |||
| Wilmot B. Harkey | 0.5% | |||
| Daniel Mack | 0.5% | |||
| Period | Filers | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 49 | 9.42 M | $212M |